Literature DB >> 20943389

Triazolyl tryptoline derivatives as β-secretase inhibitors.

Jutamas Jiaranaikulwanitch1, Chantana Boonyarat, Valery V Fokin, Opa Vajragupta.   

Abstract

Tryptoline, a core structure of ochrolifuanine E, which is a hit compound from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors. The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddition reactions. Twenty two triazolyl tryptoline derivatives were synthesized and screened for the inhibitory action against BACE1. JJCA-140 was the most potent inhibitor (IC(50)=1.49 μM) and was 100 times more selective for BACE1 than for Cat-D.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943389      PMCID: PMC3055559          DOI: 10.1016/j.bmcl.2010.09.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

Authors:  L Hong; G Koelsch; X Lin; S Wu; S Terzyan; A K Ghosh; X C Zhang; J Tang
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Fragment-based discovery of BACE1 inhibitors using functional assays.

Authors:  Robert Godemann; James Madden; Joachim Krämer; Myron Smith; Ulrike Fritz; Thomas Hesterkamp; John Barker; Sabine Höppner; David Hallett; Andrea Cesura; Andreas Ebneth; John Kemp
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

3.  Structure-based calculation of drug efficiency indices.

Authors:  Csaba Hetényi; Uko Maran; Alfonso T García-Sosa; Mati Karelson
Journal:  Bioinformatics       Date:  2007-09-05       Impact factor: 6.937

Review 4.  Computer techniques for drug development from Thai traditional medicine.

Authors:  Chak Sangma; Daungmanee Chuakheaw; Nipa Jonkon; Savitri Gadavanij
Journal:  Curr Pharm Des       Date:  2010-05       Impact factor: 3.116

5.  Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.

Authors:  Arun K Ghosh; Nagaswamy Kumaragurubaran; Lin Hong; Sarang S Kulkarni; Xiaoming Xu; Wanpin Chang; Vajira Weerasena; Robert Turner; Gerald Koelsch; Geoffrey Bilcer; Jordan Tang
Journal:  J Med Chem       Date:  2007-04-14       Impact factor: 7.446

6.  Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.

Authors:  Miles Congreve; David Aharony; Jeffrey Albert; Owen Callaghan; James Campbell; Robin A E Carr; Gianni Chessari; Suzanna Cowan; Philip D Edwards; Martyn Frederickson; Rachel McMenamin; Christopher W Murray; Sahil Patel; Nicola Wallis
Journal:  J Med Chem       Date:  2007-02-22       Impact factor: 7.446

Review 7.  The role of amyloid beta peptide 42 in Alzheimer's disease.

Authors:  Mark A Findeis
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

8.  Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.

Authors:  Michael S Malamas; Jim Erdei; Iwan Gunawan; Jim Turner; Yun Hu; Erik Wagner; Kristi Fan; Rajiv Chopra; Andrea Olland; Jonathan Bard; Steve Jacobsen; Ronald L Magolda; Menelas Pangalos; Albert J Robichaud
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

9.  Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.

Authors:  Wenjin Yang; Raymond V Fucini; Bruce T Fahr; Mike Randal; Kenneth E Lind; Melissa B Lam; Wanli Lu; Yafan Lu; Douglas R Cary; Michael J Romanowski; Dennis Colussi; Beth Pietrak; Timothy J Allison; Sanjeev K Munshi; David M Penny; Phuongly Pham; Jian Sun; Anila E Thomas; Jennifer M Wilkinson; Jeffrey W Jacobs; Robert S McDowell; Marcus D Ballinger
Journal:  Biochemistry       Date:  2009-06-02       Impact factor: 3.162

10.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

View more
  4 in total

1.  Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer's disease.

Authors:  Thanchanok Puksasook; Shinya Kimura; Sarin Tadtong; Jutamas Jiaranaikulwanitch; Jaturong Pratuangdejkul; Worawan Kitphati; Khanit Suwanborirux; Naoki Saito; Veena Nukoolkarn
Journal:  J Nat Med       Date:  2017-06-09       Impact factor: 2.343

2.  From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease.

Authors:  Jutamas Jiaranaikulwanitch; Piyarat Govitrapong; Valery V Fokin; Opa Vajragupta
Journal:  Molecules       Date:  2012-07-10       Impact factor: 4.411

Review 3.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.